5:30 PM
 | 
Mar 13, 2013
 |  BC Extra  |  Politics & Policy

Geba to resign as director of FDA's Office of Generic Drugs

Greg Geba said in an internal memo that he will resign as director of FDA's Office of Generic Drugs (OGD), effective March 15. Geba, who became director last July, said two of...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >